117104 ⎘
Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Metalloendopeptidases (3.4.24) ADAM 17 endopeptidase (3.4.24.86), i.e. TNF-alpha converting enyzme
COMPOSITIONS AND METHODS FOR TREATMENT OF SEPSIS-RELATED DISORDERS
#2NATURAL KILLER CELLS WITH ENHANCED ACTIVITY
#3Compositions and methods for treatment of sepsis-related disorders
#4VARIANTS OF TACE PRO-DOMAIN AS TNF-A INHIBITOR AND THEIR MEDICAL USE
#5Compositions and methods for treatment of sepsis-related disorders
#6Variants of TACE pro-domain as TNF-A inhibitor and their medical use
#7Gene/carrier complex for preventing or treating inflammatory diseases
#8Variants of TACE pro-domain as TNF-A inhibitor and their medical use
#9Variants of TACE pro-domain as TNF-A inhibitor and their medical use
#10TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPY
#11Treating diseases mediated by metalloprotease-shed proteins
#12Nucleic acids encoding human TNF-α convertase